Accuracy of dynamic three-dimensional magnetic resonance perfusion imaging for the detection of coronary artery disease in patients with reduced ejection fraction
Imaging · 2021
DOI: 10.1556/1647.2020.00007 ↗Kurz gefasst
Fachartikel in der Zeitschrift Imaging, 2021. Verfasst von Sabrina Oebel und 16 weiteren Autor:innen. Die Arbeit nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Swiss National Science Foundation, Bayer Healthcare, Philips Healthcare and the Swiss Heart Foundation.
Abstract (Originalsprache)
Background
To assess the accuracy of 3D cardiovascular magnetic resonance (CMR) perfusion imaging for the detection of coronary artery disease (CAD) against fractional flow reserve (FFR) and quantitative coronary angiography (QCA) in patients with reduced ejection fraction (EF).
Methods
Out of 447 patients who underwent 3D CMR perfusion imaging (at 1.5 and 3.0 T under adenosine stress and at rest) at 5 European centers, 86 cases with an EF ≤50% were identified (mean age 64 ± 11 yrs, 80% male). Significant CAD was defined as a FFR value 50%. 86 individuals matched for age, gender and major cardiovascular risk factors, were chosen as the control group.
Results
The prevalence of CAD defined by FFR (50%), P = 0.4). In relation to FFR, 3D perfusion imaging yielded a sensitivity of 84.5% (95% CI 76.0–90.4) and specificity of 77.3% (95% CI 66.7–85.3). The sensitivity of perfusion imaging was higher in patients with an EF≤50% (90.2 vs. 78.3%, P = 0.1) whereas specificity showed the reverse (62.9 vs. 90.0%, P = 0.005) The diagnostic accuracy was comparable in both subgroups (AUC 79.1 vs. 83.7%, P = 0.25). According to QCA, the prevalence of CAD was 78 vs. 72% ( P = 0.4). Perfusion imaging yielded a sensitivity and specificity of 82.1 vs. 62.9%, P = 0.01 and 79.0 vs. 95.8%, P = 0.09 respectively with a high diagnostic accuracy in both subgroups (AUC 82.0 vs. 80.5%).
Conclusion
3D-CMR perfusion imaging yields a high sensitivity and diagnostic accuracy with regards to the detection of significant CAD irrespective of left ventricular (LV) systolic function.
Förderung
- Swiss National Science Foundation
- Bayer Healthcare
- Philips Healthcare and the Swiss Heart Foundation
Zitieren
APA
Oebel, S., Gotschy, A., Paetsch, I., Jahnke, C., Plein, S., Gebker, R., Hamada, S., Frick, M., Spiczak, J. V., Polacin, M., Enseleit, F., Marx, N., Lüscher, T. F., Ruschitzka, F., Kozerke, S., Alkadhi, H., & Manka, R. (2021). Accuracy of dynamic three-dimensional magnetic resonance perfusion imaging for the detection of coronary artery disease in patients with reduced ejection fraction. Imaging. https://doi.org/10.1556/1647.2020.00007
Vancouver
Oebel S, Gotschy A, Paetsch I, Jahnke C, Plein S, Gebker R, et al. Accuracy of dynamic three-dimensional magnetic resonance perfusion imaging for the detection of coronary artery disease in patients with reduced ejection fraction. Imaging. 2021. doi:10.1556/1647.2020.00007
BibTeX
@article{Oebel2021,
author = {Oebel, Sabrina and Gotschy, Alexander and Paetsch, Ingo and Jahnke, Cosima and Plein, Sven and Gebker, Rolf and Hamada, Sandra and Frick, Michael and Spiczak, Jochen von and Polacin, Malgorzata and Enseleit, Frank and Marx, Nikolaus and Lüscher, Thomas F. and Ruschitzka, Frank and Kozerke, Sebastian and Alkadhi, Hatem and Manka, Robert},
title = {Accuracy of dynamic three-dimensional magnetic resonance perfusion imaging for the detection of coronary artery disease in patients with reduced ejection fraction},
journal = {Imaging},
year = {2021},
doi = {10.1556/1647.2020.00007}
}
EUVIMED